These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 34317679)
21. Severe Left Ventricular Hypertrophy, Small Pericardial Effusion, and Diffuse Late Gadolinium Enhancement by Cardiac Magnetic Resonance Suspecting Cardiac Amyloidosis: Endomyocardial Biopsy Reveals an Unexpected Diagnosis. Hofmann NP; Giusca S; Klingel K; Nunninger P; Korosoglou G Case Rep Cardiol; 2016; 2016():2461502. PubMed ID: 27247807 [TBL] [Abstract][Full Text] [Related]
22. Evidence of Concurrent Light Chain and Transthyretin Cardiac Amyloidosis in 2 Patients. Donnelly JP; Gabrovsek A; Sul L; Cotta C; Rodriguez ER; Tan CD; Hanna M JACC CardioOncol; 2020 Mar; 2(1):127-130. PubMed ID: 34396218 [No Abstract] [Full Text] [Related]
24. Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis. Martini N; Rizzo S; Sarais C; Cipriani A BMC Cardiovasc Disord; 2020 Oct; 20(1):466. PubMed ID: 33121442 [TBL] [Abstract][Full Text] [Related]
25. Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis. Fine NM; Davis MK; Anderson K; Delgado DH; Giraldeau G; Kitchlu A; Massie R; Narayan J; Swiggum E; Venner CP; Ducharme A; Galant NJ; Hahn C; Howlett JG; Mielniczuk L; Parent MC; Reece D; Royal V; Toma M; Virani SA; Zieroth S Can J Cardiol; 2020 Mar; 36(3):322-334. PubMed ID: 32145862 [TBL] [Abstract][Full Text] [Related]
31. Improving strategies for the diagnosis of cardiac amyloidosis. Kourelis TV; Gertz MA Expert Rev Cardiovasc Ther; 2015; 13(8):945-61. PubMed ID: 26174181 [TBL] [Abstract][Full Text] [Related]
32. A case of cardiac amyloidosis incidentally detected by bone scintigraphy. Tanaka H; Hosono M; Kanagaki M; Shimizu M; Matsubara N; Kawabata K; Miyamoto T; Itoi K Asia Ocean J Nucl Med Biol; 2021; 9(1):71-75. PubMed ID: 33392354 [TBL] [Abstract][Full Text] [Related]
36. Diagnostic Accuracy of Bone Scintigraphy for the Histopathological Diagnosis of Cardiac Transthyretin Amyloidosis-A Retrospective Austrian Multicenter Study. Verheyen N; Ungericht M; Paar L; Danninger K; Schneiderbauer-Porod S; Duca F; Cherouny B; Hoeller V; Ablasser K; Zach D; Kolesnik E; Kiblboeck D; Frick M; Bonderman D; Dierneder J; Ebner C; Weber T; Pölzl G Biomedicines; 2022 Nov; 10(12):. PubMed ID: 36551808 [TBL] [Abstract][Full Text] [Related]
37. Transthyretin cardiac amyloidosis: an under-diagnosed cause of heart failure. Molina O G; Judge D; Campbell W; Chahal H; Mugmon M J Community Hosp Intern Med Perspect; 2014; 4(5):25500. PubMed ID: 25432650 [TBL] [Abstract][Full Text] [Related]
38. A special case of hypertrophic cardiomyopathy with a differential diagnosis of isolated cardiac amyloidosis or junctophilin type 2 associated cardiomyopathy. De Bruijn S; Galloo X; De Keulenaer G; Prihadi EA; Brands C; Helbert M Acta Clin Belg; 2021 Apr; 76(2):136-143. PubMed ID: 31478477 [TBL] [Abstract][Full Text] [Related]